Laura R. D.
- Country
- Spain
- Department
- Servicio de Hematología
Research Overview
- Safety and Pharmacokinetics of XMAB24306 with Daratumumab in Relapsed/Refractory Multiple Myeloma Patients
- Phase 1 Evaluation of GSK2857916 Combined with Standard of Care in Newly Diagnosed Multiple Myeloma Patients
- Phase 1b Evaluation of Subcutaneous Daratumumab with Bispecific T Cell Redirection Antibodies in Multiple Myeloma Patients
Data & Insights
Has run more than one trial at 191 of 327 partner sites.
Specializations
Hematologic Malignancies
This investigator specializes in treating various forms of blood cancers, with particular emphasis on multiple myeloma and acute myeloid leukemia. Their research explores innovative therapeutic combinations for both newly diagnosed and relapsed cases.
- Multiple Myeloma Treatment Strategies
- Acute Myeloid Leukemia Management
- Novel Drug Combinations
Their work encompasses treatment approaches for both younger and elderly patients, including those aged 60 and above.
Therapeutic Innovation
The investigator focuses on developing combination therapies using novel agents including belantamab mafodotin, carfilzomib, and isatuximab. Their research extends to exploring the potential of emerging treatments for resistant disease forms.
- Targeted Therapy Development
- Immunotherapy Applications
- Drug Resistance Solutions
Their expertise includes evaluating treatment efficacy through advanced monitoring techniques such as minimal residual disease assessment.
Treatment Optimization
The investigator specializes in developing personalized treatment approaches for blood cancer patients, with particular attention to optimizing drug combinations and dosing strategies. Their work includes evaluation of stem cell transplantation protocols.
- Combination Therapy Protocols
- Treatment Response Assessment
- Clinical Trial Design
They focus on creating treatment strategies that balance efficacy with patient tolerability.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.